Supply Chain
Providers, compounders, individual states and the FDA all have roles to play in stemming drug shortages during the pandemic.
The over 500,000 treatment courses will be made available for hospitals based on hospitalization and inpatient data.
COVID-19 is a weak-link problem, according to Gladwell, a keynote speaker on the opening day of AHIP's Institute and Expo Online 2020.
The COVID-19 pandemic has increased demand, and North America is projected to continue its global market dominance.
The main issues are related to supply chain and the anticipated increase in ICU needs during the pandemic.
Drug Pipeline Insights Report identifies an industry trend in antibody-drug conjugate drugs, which are an extension of precision medicine.
The organizations acquired a minority stake in Prestige Ameritech, the largest domestic manufacturer of face masks.
Government and Phlow Corp. are developing a prioritized list of active pharmaceutical ingredients and medicines critically needed by health systems.
Avoiding bulk ordering in favor of smaller and more frequent shipments can save hundreds of thousands of dollars.
The action is meant to enable GE to overcome supply chain disruptions as it addresses the surge in demand for critical equipment.